Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 22-year experience at a single center-Reference-Cited by-同舟云学术

Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 22-year experience at a single center

Published:2020-12-31 Issue:6 Volume:14 Page:443-449
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Bae Sung Kwan¹,Akamatsu Nobuhisa¹²,Ichida Akihiko²,Maki Harufumi²,Nishioka Yujiro²,Kawahara Takuya³,Hoshikawa Mayumi²,Nagata Rihito²,Mihara Yuichiro²,Kawaguchi Yoshikuni²,Ishizawa Takeaki²,Arita Junichi²,Kaneko Junichi²,Tamura Sumihito²,Hasegawa Kiyoshi¹²

Affiliation:

1. Organ Transplantation Service, The University of Tokyo Hospital, Tokyo, Japan.

2. Artificial Organ and Transplantation Division, Department of Surgery, The University of Tokyo, Tokyo, Japan.

3. Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/14/6/14_2020.03336/_pdf

Reference22 articles.

1. 1. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med. 1989; 321:1092-1099.

2. 2. Dan YY, Wai CT, Yeoh KG, Lim SG. Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Liver Transpl. 2006; 12:736-746.

3. 3. Terrault N, Roche B, Samuel D. Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective. Liver Transpl. 2005; 11:716-732.

4. 4. Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl. 2000; 6:741-748.

5. 5. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med. 1993; 329:1842-1847.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma;Frontiers in Oncology;2022-09-02

2. Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study;Annals of Transplantation;2022-04-11